Nivacortol
Nivacortol (developmental code names WIN-27914 and NEBO-174; also known as nivazol and nivazole) is a synthetic glucocorticoid corticosteroid which was never marketed.[1][2][3][4]
 | |
| Clinical data | |
|---|---|
| Other names | Nivazol; Nivazole; WIN-27914; Novozola; NEBO-174; 2'-(4-Fluorophenyl)-2'-H-pregna-2,4-dien-20-yno(3,2-c)pyrazol-17-ol |
| Drug class | Corticosteroid; Glucocorticoid |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| ECHA InfoCard | 100.041.987  |
| Chemical and physical data | |
| Formula | C28H31FN2O |
| Molar mass | 430.567 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
References
- J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 881–882. ISBN 978-1-4757-2085-3.
- http://adisinsight.springer.com/drugs/800019031
- Julio Alvarez-Builla; Juan José Vaquero; José Barluenga (2011). Modern Heterocyclic Chemistry: Vol. 1. John Wiley & Sons. pp. 649–. ISBN 978-3-527-33201-4.
- Honour JW, Sudan HL, Lovell G (1986). "The determination of nivacortol in plasma using HPLC". Biomed. Chromatogr. 1 (4): 151–4. doi:10.1002/bmc.1130010404. PMID 3506827.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.